Drug Shortage Report for LOPRESOR SR 100MG

Last updated on 2020-11-07 History
Report ID 123875
Drug Identification Number 00658855
Brand name LOPRESOR SR 100MG
Common or Proper name Lopresor SR 100MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) METOPROLOL TARTRATE
Strength(s) 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 1ML
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-08-31
Actual start date 2020-08-13
Estimated end date Unknown
Actual end date 2020-11-06
Shortage status Resolved
Updated date 2020-11-07
Company comments Business decision to stop manufacturing, will be discontinued
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-11-07 English Compare
v9 2020-11-06 French Compare
v8 2020-11-06 French Compare
v7 2020-11-06 English Compare
v6 2020-11-04 French Compare
v5 2020-11-04 English Compare
v4 2020-10-07 French Compare
v3 2020-10-07 English Compare
v2 2020-09-08 French Compare
v1 2020-09-08 English Compare

Showing 1 to 10 of 10